REQUEST A DEMO
Total
USD $0.00
Search more companies

Taiwan Biotech Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Taiwan Biotech Co., Ltd. Profile Updated: November 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Established in 1962, Taiwan Biotech Co., Ltd. is engaged in the research and development, manufacturing, representation and sales distribution of modern medicine, active pharmaceutical ingredients, medical equipment, oral and optical drugs and equipment supplies, biotech formulations and health food, traditional Chinese herbal medicine and related import/export operations.

Headquarters
22, Jie-Shou Road
Taoyuan City; Taoyuan City;

Contact Details: Purchase the Taiwan Biotech Co., Ltd. report to view the information.

Website: http://www.sintong.com

Basic Information
Total Employees:
Purchase the Taiwan Biotech Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Taiwan Biotech Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Taiwan Biotech Co., Ltd. report to view the information.
Incorporation Date:
October 09, 1962
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Executive Vice President
Ownership Details
Purchase this report to view the information.
11.67%
Purchase this report to view the information.
9.63%
Purchase this report to view the information.
6.77%
Purchase this report to view the information.
0.57%
Purchase this report to view the information.
0.09%
Subsidiaries
復享生技股份有限公司
100%
澳門茂鑫科技化工產品有限公司 (China)
100%
英屬維京群島商福源集團有限公司 (United Kingdom)
100%
Company Performance
Financial values in the chart are available after Taiwan Biotech Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
7.47%
Total operating revenue
8.88%
Operating profit (EBIT)
26.91%
EBITDA
23.51%
Net Profit (Loss) for the Period
19.56%
Total assets
6.05%
Total equity
9.49%
Operating Profit Margin (ROS)
1.48%
Net Profit Margin
0.88%
Return on Equity (ROE)
0.32%
Debt to Equity Ratio
2.5%
Quick Ratio
0.14%
Cash Ratio
0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?